Balyasny Asset Management LLC Olema Pharmaceuticals, Inc. Transaction History
Balyasny Asset Management LLC
- $57.8 Billion
- Q1 2025
A detailed history of Balyasny Asset Management LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 113,018 shares of OLMA stock, worth $513,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,018
Previous 1,127,589
89.98%
Holding current value
$513,101
Previous $6.57 Million
93.55%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding OLMA
# of Institutions
134Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$31.1 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$30.6 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$24 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$18.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$15.6 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $184M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...